Shumez H,Prasad PV,Kaviarasan PK,Deepika R .2015 .Intralesional platelet rich plasma vs intralesional triamcinolone in the treatment of alopecia areata: a comparative study. Int J Med Res Health Sci, 4(1) : 118-22.
Pratt CH,King LE,Messenger AG,Christiano AM,Sundberg JP .2017 .Alopecia areata. Nat Rev Dis Primers, 3(1) : 1-7.
Seetharam KA .2013 .Alopecia areata: An update. Indian J Dermatol Venereol Leprol, 79 : 563.
Lundin M,Chawa S,Sachdev A,Bhanusali D,Seiffert-Sinha K,Sinha AA .2014 .Gender differences in alopecia areata. J Drugs Dermatol, 13(4) : 409-13.
Abi Thomas E,Kadyan RS .2008 .Alopecia areata and autoimmunity: a clinical study. Indian J Dermatol, 53(2) : 70.
Strazzulla LC,Wang EH,Avila L,Sicco KL,Brinster N,Christiano AM,Shapiro J .2018 .Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol, 78(1) : 1-2.
Messenger AG,Slater DN,Bleehen SS .1986 .Alopecia areata: alterations in the hair growth cycle and correlation with the follicular pathology. Br J Dermatol, 114(3) : 337-47.
Egawa K,Ono T. .2004 .Topical vitamin D3 derivatives for recalcitrant warts in three immunocompromised patients. Br J Dermatol, 150(2) : 374-6.
Demay MB,MacDonald PN,Skorija K,Dowd DR,Cianferotti L,Cox M. .2007 .Role of the vitamin D receptor in hair follicle biology. J Steroid Biochem Mol Biol, 103(3-5) : 344-6.
Kim DH,Lee JW,Kim IS,Choi SY,Lim YY,Kim HM,Kim BJ,Kim MN .2012 .Successful treatment of alopecia areata with topical calcipotriol. Ann Dermatol, 24(3) : 341-4.
Lang PO,Aspinall R .2015 .Can we translate vitamin D immunomodulating effect on innate and adaptive immunity to vaccine response?. Nutrients, 7(3) : 2044-60.
Clancy N,Onwuneme C,Carroll A,McCarthy R,McKenna MJ,Murphy N,Molloy EJ .2013 .Vitamin D and neonatal immune function. J Matern Fetal Neonatal Med, 26(7) : 639-46.
van Etten E,Mathieu C .2005 .Immunoregulation by 1, 25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol, 97(1-2) : 93-101.
Lin X,Meng X .2019 .Vitamin D and alopecia areata: possible roles in pathogenesis and potential implications for therapy. Am J Trans Res, 11(9) : 5285.
Reynolds NJ,Al‐Daraji WI .2002 .Calcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatology. Clin Exp Dermatol, 27(7) : 555-61.
Heidt S,Roelen DL,Eijsink C,Eikmans M,Van Kooten C,Claas FH,Mulder A .2010 .Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help. Clin Exp Immunol, 159(2) : 199-207.
Baksh S,Burakoff SJ . .The role of calcineurin in lymphocyte activation. InSeminars in immunology 2000 Aug, 12(4) : 405-415.
Grassberger M,Steinhoff M,Schneider D,Luger TA .2004 .Pimecrolimus-an antiinflammatory drug targeting the skin. Exp Dermatol, 13(12) : 721-30.
King BA,Senna MM,Ohyama M,Tosti A,Sinclair RD,Ball S,Ko JM,Glashofer M,Pirmez R,Shapiro J. Defining .2022 .Severity in Alopecia Areata: Current Perspectives and a Multidimensional Framework. Dermatol Ther, 12(4) : 825-34.
Cerman AA,Solak SS,Altunay İ,Küçükünal N.,Dermatol J Drugs .2015 .Topical Calcipotriol Therapy for Mild-to-Moderate Alopecia Areata: A Retrospective Study. , 14(6) : 616-20.
Narang T,Daroach M,Kumaran MS .2017 .Efficacy and safety of topical calcipotriol in management of alopecia areata: A pilot study. Dermatol Ther, 30(3) : e12464.
Molinelli E,Campanati A,Brisigotti V,Sapigni C,Paolinelli M,Offidani A .2020 .Efficacy and safety of topical calcipotriol 0.005% versus topical clobetasol 0.05% in the management of Alopecia Areata: an intra subject pilot study. Dermatol Ther, 10 : 515-21.
Gupta M,SinGh S .2021 .Comparative Evaluation of Efficacy Between Topical Calcipotriol Used Along With Topical Clobetasol And Topical Clobetasol Monotherapy In Treatment Of Alopecia Areata: A Randomised Clinical Trial. J Clin Diagnost Res, 15(4) : WC05-WC08.
Hossain MS,Miah MT,Khan MZ,Khondker L,Hasan MR .2015 .Efficacy of topical tacrolimus 0.1% and clobetasol propionate 0.05% in the treatment of alopecia areata. J Pak Assoc Dermatol, 25(3) : 197-201.
Ullah F,Dawood M,Noor N,Hameed S .2022 .Ointment and Topical Tacrolimus 0.1% Ointment in Treatment of Alopecia Areata. Pak J Med Health Sci, 16(06) : 133.
Saleem A,Khan M,Mashori GR,SamdanI A,Kazmi SA .2009 .Comparison of effectiveness of topical tacrolimus and betamethasone with soft paraffin in the treatment of patchy alopecia areata. Pak J Med Sci, 25(5) : 833-6.
Nassar A,Elradi M,Radwan M,Albalat W. .2023 .Comparative evaluation of the efficacy of topical tacrolimus 0.03% and topical calcipotriol 0.005% mixed with betamethasone dipropionate versus topical clobetasol 0.05% in treatment of alopecia areata: A clinical and trichoscopic study. J Cosmet Dermatol, 22(4) : 1297-1303.
Herkal KC,Patil S,Yogeesh HR,Thimmappa RM,Cholachaguddar L .2013 .Study of therapeutic comparison of tacrolimus 0.1% and minoxidil 2% in alopecia areata. Our Dermatol Online, 4(3) : 306-10.
Price VH,Willey A,Chen BK .2005 .Topical tacrolimus in alopecia areata. J Am Acad Dermatol, 52(1) : 138-9.
Bimbi C,Kyriakou G,Wollina U .2021 .Occlusive treatment enhances efficacy of tacrolimus 0.1% in a pediatric patient with severe alopecia areata: Case report and literature review. Pediatr Dermatol, 38(1) : 339-40.
Price VH,Willey A,Chen BK .2005 .Topical tacrolimus in alopecia areata. J Am Acad Dermatol, 52(1) : 138-9.